1
|
Soleimani M, Naderan M. Management Strategies of Ocular Chemical Burns: Current Perspectives. Clin Ophthalmol 2020; 14:2687-2699. [PMID: 32982161 PMCID: PMC7501954 DOI: 10.2147/opth.s235873] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2020] [Accepted: 08/20/2020] [Indexed: 11/25/2022] Open
Abstract
Ocular chemical burns are absolute ophthalmic emergencies and require immediate management to minimize devastating sequelae. Management of alkali and acid burns is started at the scene of the accident by copious irrigation. Treatment is directed at improving epithelial integrity and stromal stability, reduction of undue inflammation, and prevention or timely management of complications. To ascertain the best possible outcome, numerous biological medications and surgical interventions have been merged into conventional therapeutic regimens. These include autologous and umbilical cord serum preparations, platelet-rich plasma, amniotic membrane transplantation, limbal stem-cell transplantation, and anti-angiogenic agents.
Collapse
Affiliation(s)
- Mohammad Soleimani
- Ocular Trauma and Emergency Department, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran
| | - Morteza Naderan
- Ocular Trauma and Emergency Department, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
2
|
Miyake M, Kakizawa Y, Tobori N, Kurioka M, Tabuchi N, Kon R, Shimokawa N, Tsujino Y, Takagi M. Membrane permeation of giant unilamellar vesicles and corneal epithelial cells with lipophilic vitamin nanoemulsions. Colloids Surf B Biointerfaces 2018; 169:444-452. [DOI: 10.1016/j.colsurfb.2018.05.052] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2017] [Revised: 05/08/2018] [Accepted: 05/23/2018] [Indexed: 01/09/2023]
|
3
|
Treatment of acute ocular chemical burns. Surv Ophthalmol 2017; 63:214-235. [PMID: 28935121 DOI: 10.1016/j.survophthal.2017.09.005] [Citation(s) in RCA: 104] [Impact Index Per Article: 14.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2016] [Revised: 09/08/2017] [Accepted: 09/11/2017] [Indexed: 01/15/2023]
Abstract
Ocular chemical burns are an ophthalmic emergency and are responsible for 11.5%-22.1% of ocular injuries. Immediate copious irrigation is universally recommended in acute ocular burns to remove the offending agent and minimize damage. Conventional medical therapy consists of the use of agents that promote epithelialization, minimize inflammation, and prevent cicatricial complications. Biological fluids such as autologous serum, umbilical cord blood serum, platelet-rich plasma, and amniotic membrane suspension are a rich source of growth factors and promote healing when used as adjuncts to conventional therapy. Surgical treatment of acute ocular burns includes the debridement of the necrotic tissue, application of tissue adhesives, tenoplasty, and tectonic keratoplasty. Amniotic membrane transplantation is a novel surgical treatment that is increasingly being used as an adjunct to conventional treatment to promote epithelial healing, minimize pain, and restore visual acuity. Various experimental treatments that aim to promote wound healing and minimize inflammation are being evaluated such as human mesenchymal and adipose stem cells, beta-1,3 glucan, angiotensin-converting enzyme inhibitors, cultivated fibroblasts, zinc desferrioxamine, antifibrinolytic agents, antioxidants, collagen cross-linking, and inhibitors of corneal neovascularization.
Collapse
|
4
|
Toshida H, Funaki T, Ono K, Tabuchi N, Watanabe S, Seki T, Otake H, Kato T, Ebihara N, Murakami A. Efficacy and safety of retinol palmitate ophthalmic solution in the treatment of dry eye: a Japanese Phase II clinical trial. DRUG DESIGN DEVELOPMENT AND THERAPY 2017; 11:1871-1879. [PMID: 28694687 PMCID: PMC5491700 DOI: 10.2147/dddt.s137825] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Abstract
Purpose The purpose of this study was to investigate the efficacy and safety of the administration of retinol palmitate (VApal) ophthalmic solution (500 IU/mL) for the treatment of patients with dry eye. Patients and methods This study included 66 patients with dry eye. After a 2-week washout period, patients were randomized (1:1) into either a VApal ophthalmic solution or a placebo group, and a single drop of either solution was administered six times daily for 4 weeks. Efficacy measures were 12 subjective symptoms, rose bengal (RB) and fluorescein staining scores, tear film breakup time, and tear secretion. Safety measures included clinical blood and urine analyses and adverse event recordings. Results In comparisons of the two groups, the mean change in RB staining score from baseline was significantly lower in the VApal group at 2 and 4 weeks (P<0.05 and P<0.01, respectively). Furthermore, the fluorescein clearance rate (fluorescein staining score) was significantly higher in the VApal group at 4 weeks (P<0.05). The VApal group showed a significant improvement in blurred vision at 1 and 2 weeks (P<0.01 and P<0.05, respectively), and the mean change in the total score for subjective symptoms from baseline was significantly lower in the VApal group at 1 week (P<0.05). In before- and after-intervention comparisons, the fluorescein and RB staining scores showed improvement in both groups. Improvement was noted for 11 subjective symptoms in the VApal group and for seven symptoms in the placebo group. No significant differences in adverse events and reactions were found between the groups. Conclusion VApal ophthalmic solution (500 IU/mL) is safe and effective for the treatment of patients with dry eye.
Collapse
Affiliation(s)
- Hiroshi Toshida
- Department of Ophthalmology, Juntendo University Shizuoka Hospital, Shizuoka
| | - Toshinari Funaki
- Department of Ophthalmology, Juntendo University Graduate School of Medicine
| | - Koichi Ono
- Department of Ophthalmology, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo
| | - Nobuhito Tabuchi
- Pharmaceutical Research Laboratories, Lion Corporation, Kanagawa
| | - Sota Watanabe
- Pharmaceutical Research Laboratories, Lion Corporation, Kanagawa
| | | | | | | | - Nobuyuki Ebihara
- Department of Ophthalmology, Juntendo University Urayasu Hospital, Chiba, Japan
| | - Akira Murakami
- Department of Ophthalmology, Juntendo University Graduate School of Medicine
| |
Collapse
|
5
|
Tabuchi N, Toshida H, Koike D, Odaka A, Suto C, Ohta T, Murakami A. Effect of Retinol Palmitate on Corneal and Conjunctival Mucin Gene Expression in a Rat Dry Eye Model After Injury. J Ocul Pharmacol Ther 2017; 33:24-33. [DOI: 10.1089/jop.2015.0161] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Nobuhito Tabuchi
- Pharmaceutical Research Laboratories No.1, Research and Development Headquarters, Lion Corporation, Kanagawa, Japan
| | - Hiroshi Toshida
- Department of Ophthalmology, Juntendo University Shizuoka Hospital, Shizuoka, Japan
| | - Daisuke Koike
- Pharmaceutical Research Laboratories No.1, Research and Development Headquarters, Lion Corporation, Kanagawa, Japan
| | - Akito Odaka
- Human and Environmental Safety Evaluation Center, Research and Development Headquarters, Lion Corporation, Kanagawa, Japan
| | - Chikako Suto
- Department of Ophthalmology, Tokyo Women's Medical University Medical Center East, Tokyo, Japan
| | - Toshihiko Ohta
- Department of Ophthalmology, Juntendo University Shizuoka Hospital, Shizuoka, Japan
| | - Akira Murakami
- Department of Ophthalmology, Juntendo University School of Medicine, Tokyo, Japan
| |
Collapse
|
6
|
Comptour A, Rouzaire M, Belville C, Bonnin N, Daniel E, Chiambaretta F, Blanchon L, Sapin V. Lysyl oxidase-like 4 involvement in retinoic acid epithelial wound healing. Sci Rep 2016; 6:32688. [PMID: 27597564 PMCID: PMC5011693 DOI: 10.1038/srep32688] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2016] [Accepted: 08/11/2016] [Indexed: 01/09/2023] Open
Abstract
Vitamin A and its active forms (retinoic acids/RAs) are known to have pro-healing properties, but their mechanisms of action are still poorly understood. This work aimed to identify the cellular and molecular processes by which atRA (all-trans RA) improves wound healing, using an in vivo model of mouse corneal alkali burns and an in vitro cellular human corneal epithelial injury model. Regulation by atRA has been studied on most of the cellular events that occur in wound healing. We investigated the direct influence of atRA on a specific target gene known to be involved in the extracellular matrix (ECM) dynamics, one of the pathways contributing to epithelial repair. Our results demonstrate that atRA promotes corneal epithelial wound healing by acting preferentially on migration. The induction of lysyl oxidase-like 4 (LOXL4) expression by atRA in the corneal epithelium environment was established as essential in the mechanism of atRA-dependent wound healing. Our study describes for the first time a direct link between a retinoic-induced gene and protein, LOXL4, and its general clinical pro-healing properties in ECM dynamics.
Collapse
Affiliation(s)
- Aurélie Comptour
- Clermont Université, Université d’Auvergne, EA7281 – Retinoids, Reproduction Developmental Diseases, School of Medicine, F-63000 Clermont-Ferrand, France
| | - Marion Rouzaire
- Clermont Université, Université d’Auvergne, EA7281 – Retinoids, Reproduction Developmental Diseases, School of Medicine, F-63000 Clermont-Ferrand, France
| | - Corinne Belville
- Clermont Université, Université d’Auvergne, EA7281 – Retinoids, Reproduction Developmental Diseases, School of Medicine, F-63000 Clermont-Ferrand, France
- Clermont Université, Université d’Auvergne, GReD, F-63000 Clermont-Ferrand, France
| | - Nicolas Bonnin
- Clermont Université, Université d’Auvergne, EA7281 – Retinoids, Reproduction Developmental Diseases, School of Medicine, F-63000 Clermont-Ferrand, France
- CHU Clermont-Ferrand, Ophthalmology Department, F-63000 Clermont-Ferrand, France
| | - Estelle Daniel
- Clermont Université, Université d’Auvergne, EA7281 – Retinoids, Reproduction Developmental Diseases, School of Medicine, F-63000 Clermont-Ferrand, France
- CHU Clermont-Ferrand, Ophthalmology Department, F-63000 Clermont-Ferrand, France
| | - Frédéric Chiambaretta
- Clermont Université, Université d’Auvergne, EA7281 – Retinoids, Reproduction Developmental Diseases, School of Medicine, F-63000 Clermont-Ferrand, France
- CHU Clermont-Ferrand, Ophthalmology Department, F-63000 Clermont-Ferrand, France
| | - Loïc Blanchon
- Clermont Université, Université d’Auvergne, EA7281 – Retinoids, Reproduction Developmental Diseases, School of Medicine, F-63000 Clermont-Ferrand, France
| | - Vincent Sapin
- Clermont Université, Université d’Auvergne, EA7281 – Retinoids, Reproduction Developmental Diseases, School of Medicine, F-63000 Clermont-Ferrand, France
| |
Collapse
|
7
|
Kim DW, Lee SH, Shin MJ, Kim K, Ku SK, Youn JK, Cho SB, Park JH, Lee CH, Son O, Sohn EJ, Cho SW, Park JH, Kim HA, Han KH, Park J, Eum WS, Choi SY. PEP-1-FK506BP inhibits alkali burn-induced corneal inflammation on the rat model of corneal alkali injury. BMB Rep 2016; 48:618-23. [PMID: 25817214 PMCID: PMC4911203 DOI: 10.5483/bmbrep.2015.48.11.041] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2015] [Indexed: 11/20/2022] Open
Abstract
FK506 binding protein 12 (FK506BP) is a small peptide with a single FK506BP domain that is involved in suppression of immune response and reactive oxygen species. FK506BP has emerged as a potential drug target for several inflammatory diseases. Here, we examined the protective effects of directly applied cell permeable FK506BP (PEP-1-FK506BP) on corneal alkali burn injury (CAI). In the cornea, there was a significant decrease in the number of cells expressing pro-inflammation, apoptotic, and angiogenic factors such as TNF-α, COX-2, and VEGF. Both corneal opacity and corneal neovascularization (CNV) were significantly decreased in the PEP-1-FK506BP treated group. Our results showed that PEP-1-FK506BP can significantly inhibit alkali burn-induced corneal inflammation in rats, possibly by accelerating corneal wound healing and by reducing the production of angiogenic factors and inflammatory cytokines. These results suggest that PEP-1-FK506BP may be a potential therapeutic agent for CAI. [BMB Reports 2015; 48(11): 618-623]
Collapse
Affiliation(s)
- Dae Won Kim
- Department of Biochemistry and Molecular Biology, Research Institute of Oral Sciences, College of Dentistry, Gangnung-Wonju National University, Gangneung 25457, Korea
| | - Sung Ho Lee
- R&D Center, Lumieye Genetics Co., Ltd. Seoul 06198, Korea
| | - Min Jea Shin
- Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chunchon 24252, Korea
| | - Kibom Kim
- R&D Center, Lumieye Genetics Co., Ltd. Seoul 06198, Korea
| | - Sae Kwang Ku
- Department of Anatomy and Histology, College of Korean Medicine, Daegu Haany University, Gyeongsan 38610, Korea
| | - Jong Kyu Youn
- Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chunchon 24252, Korea
| | - Su Bin Cho
- Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chunchon 24252, Korea
| | - Jung Hwan Park
- Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chunchon 24252, Korea
| | - Chi Hern Lee
- Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chunchon 24252, Korea
| | - Ora Son
- Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chunchon 24252, Korea
| | - Eun Jeong Sohn
- Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chunchon 24252, Korea
| | - Sung-Woo Cho
- Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine, Seoul 05505, Korea
| | - Jong Hoon Park
- Department of Biological Sciences, Sookmyung Women's University, Seoul 04310, Korea
| | - Hyun Ah Kim
- Division of Rheumatology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Pyongchon 14068, Korea
| | - Kyu Hyung Han
- Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chunchon 24252, Korea
| | - Jinseu Park
- Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chunchon 24252, Korea
| | - Won Sik Eum
- Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chunchon 24252, Korea
| | - Soo Young Choi
- Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chunchon 24252, Korea
| |
Collapse
|
8
|
Matsuki M, Miyake M, Ogura T, Hyodo R, Tobori N, Sakai H, Glatter O. Structural analysis and adsorbability onto the corneal epithelial cells-model interface of vitamin nano-emulsions. J Oleo Sci 2014; 63:903-9. [PMID: 25099912 DOI: 10.5650/jos.ess14069] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
O/W nano-emulsions can be used as effective drug carriers of hydrophobic active ingredients in an aqueous solution, because nano-emulsions are comparatively stable and their structure can be controlled by changing the compositions and the preparation methods. In this paper, we focused on vitamin A and its derivatives (VA), which are among the widely-used lipophilic active ingredients, and tried to develop the nano-emulsions, which can bring out the efficiency of VA for the healing of injured corneas, with the detailed structural analysis of them using the small-angle X-ray scattering (SAXS) method. As a result, we elucidated that the nano-emulsions bearing the hydrophobic oil/water interface can be prepared by decreasing the surfactant concentration against vitamins. Moreover, we clarified that the nano-emulsions composed of lower surfactant concentration tend to adsorb VA onto the corneal epithelial cells-model interface. Therefore it is necessary to prepare the nano-emulsions, which have the hydrophobic oil/water interface for improving the adsorbability onto cell membranes.
Collapse
Affiliation(s)
- Maiko Matsuki
- Functional Materials Science Research Laboratories, R & D, LION CORPORATION
| | | | | | | | | | | | | |
Collapse
|
9
|
Odaka A, Toshida H, Ohta T, Tabuchi N, Koike D, Suto C, Murakami A. Efficacy of retinol palmitate eye drops for dry eye in rabbits with lacrimal gland resection. Clin Ophthalmol 2012; 6:1585-93. [PMID: 23055683 PMCID: PMC3468284 DOI: 10.2147/opth.s35584] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023] Open
Abstract
Purpose We examined the efficacy of retinol palmitate (VApal) for dry eyes using dry eye model rabbits whose lacrimal glands were resected. Materials and methods After alkaline injury on keratoconjunctival epithelium, VApal eye drops were administered 6 times a day for 7 days. The efficacy of VApal was also compared with that of 0.1% hyaluronic acid eye drops. Results The fluorescein staining and rose bengal scores showed a significant decrease compared with the score in the vehicle group at 7 days (P < 0.05) in the 1000 IU/mL VApal group and at both 3 days (P < 0.05) and 7 days (P < 0.01) in the 1500 IU/mL VApal group. Histological examination revealed recovery of the corneal epithelium, and PAS staining disclosed the recovery of mucin-producing lower palpebral conjunctival goblet cells after 7 days in the 1500 IU/mL VApal group compared with the vehicle group. Results from impression cytology showed a significant increase in density of conjunctival goblet cells compared with that in the vehicle group after 7 days in the 1000 IU/mL VApal group and after 3 and 7 days in the 1500 IU/mL VApal group. There were no significant changes in tear flow in either group. Topical application of VApal at 1500 IU/mL showed greater improvement than 0.1% hyaluronic acid in both fluorescein and rose bengal score and in the density of conjunctival goblet cells. Conclusion It is suggested that VApal is effective for the improvement of keratoconjunctival epithelial damage associated with tear abnormalities, such as dry eyes.
Collapse
Affiliation(s)
- Akito Odaka
- Human and Environmental Safety Evaluation Center, Lion Corporation, Kanagawa, Japan
| | | | | | | | | | | | | |
Collapse
|
10
|
Hattori M, Shimizu K, Katsumura K, Oku H, Sano Y, Matsumoto K, Yamaguchi Y, Ikeda T. Effects of all-trans retinoic acid nanoparticles on corneal epithelial wound healing. Graefes Arch Clin Exp Ophthalmol 2011; 250:557-63. [DOI: 10.1007/s00417-011-1849-8] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2011] [Revised: 09/30/2011] [Accepted: 10/05/2011] [Indexed: 02/07/2023] Open
|